With Gilead’s $7.8 billion buyout of Arcellx complete, the California pharma is consolidating some of the workforce at the acquired company.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
With Gilead’s $7.8 billion buyout of Arcellx complete, the California pharma is consolidating some of the workforce at the acquired company.